Literature DB >> 20634301

BTBR Ob/Ob mutant mice model progressive diabetic nephropathy.

Kelly L Hudkins1, Warangkana Pichaiwong, Tomasz Wietecha, Jolanta Kowalewska, Miriam C Banas, Min W Spencer, Anja Mühlfeld, Mariko Koelling, Jeffrey W Pippin, Stuart J Shankland, Bardia Askari, Mary E Rabaglia, Mark P Keller, Alan D Attie, Charles E Alpers.   

Abstract

There remains a need for robust mouse models of diabetic nephropathy (DN) that mimic key features of advanced human DN. The recently developed mouse strain BTBR with the ob/ob leptin-deficiency mutation develops severe type 2 diabetes, hypercholesterolemia, elevated triglycerides, and insulin resistance, but the renal phenotype has not been characterized. Here, we show that these obese, diabetic mice rapidly develop morphologic renal lesions characteristic of both early and advanced human DN. BTBR ob/ob mice developed progressive proteinuria beginning at 4 weeks. Glomerular hypertrophy and accumulation of mesangial matrix, characteristic of early DN, were present by 8 weeks, and glomerular lesions similar to those of advanced human DN were present by 20 weeks. By 22 weeks, we observed an approximately 20% increase in basement membrane thickness and a >50% increase in mesangial matrix. Diffuse mesangial sclerosis (focally approaching nodular glomerulosclerosis), focal arteriolar hyalinosis, mesangiolysis, and focal mild interstitial fibrosis were present. Loss of podocytes was present early and persisted. In summary, BTBR ob/ob mice develop a constellation of abnormalities that closely resemble advanced human DN more rapidly than most other murine models, making this strain particularly attractive for testing therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634301      PMCID: PMC3013527          DOI: 10.1681/ASN.2009121290

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  38 in total

1.  Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

Authors:  Takahiko Nakagawa; Waichi Sato; Olena Glushakova; Marcelo Heinig; Tracy Clarke; Martha Campbell-Thompson; Yukio Yuzawa; Mark A Atkinson; Richard J Johnson; Byron Croker
Journal:  J Am Soc Nephrol       Date:  2007-01-03       Impact factor: 10.121

2.  Validation of volume-pressure recording tail-cuff blood pressure measurements.

Authors:  Minjie Feng; Steven Whitesall; Yunyu Zhang; Martin Beibel; Louis D'Alecy; Keith DiPetrillo
Journal:  Am J Hypertens       Date:  2008-10-09       Impact factor: 2.689

Review 3.  Leptin resistance and obesity.

Authors:  Pablo J Enriori; Anne E Evans; Puspha Sinnayah; Michael A Cowley
Journal:  Obesity (Silver Spring)       Date:  2006-08       Impact factor: 5.002

4.  A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility.

Authors:  Mark P Keller; YounJeong Choi; Ping Wang; Dawn Belt Davis; Mary E Rabaglia; Angie T Oler; Donald S Stapleton; Carmen Argmann; Kathy L Schueler; Steve Edwards; H Adam Steinberg; Elias Chaibub Neto; Robert Kleinhanz; Scott Turner; Marc K Hellerstein; Eric E Schadt; Brian S Yandell; Christina Kendziorski; Alan D Attie
Journal:  Genome Res       Date:  2008-03-17       Impact factor: 9.043

5.  Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis.

Authors:  Shunhua Guo; Jolanta Kowalewska; Tomasz A Wietecha; Masayuki Iyoda; Li Wang; Kenneth Yi; Min Spencer; Miriam Banas; Sanda Alexandrescu; Kelly L Hudkins; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

6.  Association between diencephalic thyroliberin and arterial blood pressure in agouti-yellow and ob/ob mice may be mediated by leptin.

Authors:  Adriana L Burgueño; Maria S Landa; Mariano L Schuman; Azucena L Alvarez; Julieta Carabelli; Silvia I García; Carlos J Pirola
Journal:  Metabolism       Date:  2007-10       Impact factor: 8.694

Review 7.  Proteinuria in diabetic kidney disease: a mechanistic viewpoint.

Authors:  J A Jefferson; S J Shankland; R H Pichler
Journal:  Kidney Int       Date:  2008-04-16       Impact factor: 10.612

8.  SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse.

Authors:  Mark O Goodarzi; Donna M Lehman; Kent D Taylor; Xiuqing Guo; Jinrui Cui; Manuel J Quiñones; Susanne M Clee; Brian S Yandell; John Blangero; Willa A Hsueh; Alan D Attie; Michael P Stern; Jerome I Rotter
Journal:  Diabetes       Date:  2007-04-10       Impact factor: 9.461

9.  Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.

Authors:  Tomoki Kosugi; Marcelo Heinig; Takahiro Nakayama; Thomas Connor; Yukio Yuzawa; Qiuhong Li; William W Hauswirth; Maria B Grant; Byron P Croker; Martha Campbell-Thompson; Li Zhang; Mark A Atkinson; Mark S Segal; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

Review 10.  Mouse models of diabetic nephropathy.

Authors:  Frank C Brosius; Charles E Alpers; Erwin P Bottinger; Matthew D Breyer; Thomas M Coffman; Susan B Gurley; Raymond C Harris; Masao Kakoki; Matthias Kretzler; Edward H Leiter; Moshe Levi; Richard A McIndoe; Kumar Sharma; Oliver Smithies; Katalin Susztak; Nobuyuki Takahashi; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

View more
  102 in total

1.  Animal models of regression/progression of kidney disease.

Authors:  Beom Jin Lim; Hai-Chun Yang; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2014

2.  B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Authors:  Elena Gagliardini; Rubina Novelli; Daniela Corna; Carlamaria Zoja; Barbara Ruggiero; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

3.  Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.

Authors:  D K Kim; B Y Nam; J J Li; J T Park; S H Lee; D H Kim; J Y Kim; H Y Kang; S H Han; T H Yoo; D S Han; S W Kang
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

4.  Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney.

Authors:  Dilip K Deb; Riyue Bao; Yan Chun Li
Journal:  FASEB J       Date:  2017-02-01       Impact factor: 5.191

5.  Noninvasive imaging of retinal morphology and microvasculature in obese mice using optical coherence tomography and optical microangiography.

Authors:  Zhongwei Zhi; Jennifer R Chao; Tomasz Wietecha; Kelly L Hudkins; Charles E Alpers; Ruikang K Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-20       Impact factor: 4.799

6.  PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease.

Authors:  Yajuan Li; Qingsong Hu; Chunlai Li; Ke Liang; Yu Xiang; Heidi Hsiao; Tina K Nguyen; Peter K Park; Sergey D Egranov; Chandrashekar R Ambati; Nagireddy Putluri; David H Hawke; Leng Han; Mien-Chie Hung; Farhad R Danesh; Liuqing Yang; Chunru Lin
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

7.  Reversibility of structural and functional damage in a model of advanced diabetic nephropathy.

Authors:  Warangkana Pichaiwong; Kelly L Hudkins; Tomasz Wietecha; Tri Q Nguyen; Chiraporn Tachaudomdach; Wei Li; Bardia Askari; Takahisa Kobayashi; Kevin D O'Brien; Jeffrey W Pippin; Stuart J Shankland; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

8.  Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.

Authors:  Jan Wysocki; Minghao Ye; Ahmed M Khattab; Agnes Fogo; Aline Martin; Nicolae Valentin David; Yashpal Kanwar; Mark Osborn; Daniel Batlle
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

9.  An enigma: does a high-protein diet accelerate renal damage in humans? Lessons from diabetic animal models.

Authors:  Ming Zhan; Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-16

10.  Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.

Authors:  Charles E Alpers; Peter B Imrey; Kelly L Hudkins; Tomasz A Wietecha; Milena Radeva; Michael Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Yan-Ting Shiu; Christi M Terry; Alik Farber; Gerald J Beck; Harold I Feldman; John W Kusek; Jonathan Himmelfarb
Journal:  J Am Soc Nephrol       Date:  2017-07-19       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.